(b)(4).
Investigation summary: the asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.
Further investigation of this individual incident will not be undertaken.
The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa- (b)(4).
Ongoing post market surveillance is conducted per our procedures for this product.
Initial reporter occupation: lawyer.
(b)(4).
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
No 510(k) number provided because this implant is sold internationally with different indications for use; it is currently sold in the us under a different part number.
The correction/removal reporting number listed applies to the corresponding product code sold domestically.
|
English translation of (b)(6) legal document received.
This is a request for initiation of mediation procedure alleging progressively severe pain, limping gait, instability, functional limitations of the lower limb, inflammation, presence of accumulation of chromium and cobalt metal ions in the patient's blood leading to metallosis and presence of a voluminous cyst in the right coxofemoral region.
The document further indicates that the patient developed moderate to severe persistent depressive disorder related to stress directly connected to the consequences of the trauma suffered by the patient, partly increased by her knowledge of the damage caused by having the depuy asr prosthetic system.
This resulted to severe anxiety and significant obsessive-phobic manifestations, depressed mood, excessive irritability and reactivity.
Doi: somewhere between (b)(6) 2009 - dor: no revision reported (right hip).
|